• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HCV 诱导的 miR-21 通过靶向 MyD88 和 IRAK1 促进宿主免疫系统逃避。

HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1.

机构信息

State Key Laboratory of Virology, College of Life Sciences, and Chinese-French Liver Disease Research Institute at Zhongnan Hospital, Wuhan University, Wuhan, Hubei, PR China.

出版信息

PLoS Pathog. 2013;9(4):e1003248. doi: 10.1371/journal.ppat.1003248. Epub 2013 Apr 25.

DOI:10.1371/journal.ppat.1003248
PMID:23633945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3635988/
Abstract

Upon recognition of viral components by pattern recognition receptors, such as the toll-like receptors (TLRs) and retinoic acid-inducible gene I (RIG-I)-like helicases, cells are activated to produce type I interferon (IFN) and proinflammatory cytokines. These pathways are tightly regulated by the host to prevent an inappropriate cellular response, but viruses can modulate these pathways to proliferate and spread. In this study, we revealed a novel mechanism in which hepatitis C virus (HCV) evades the immune surveillance system to proliferate by activating microRNA-21 (miR-21). We demonstrated that HCV infection upregulates miR-21, which in turn suppresses HCV-triggered type I IFN production, thus promoting HCV replication. Furthermore, we demonstrated that miR-21 targets two important factors in the TLR signaling pathway, myeloid differentiation factor 88 (MyD88) and interleukin-1 receptor-associated kinase 1 (IRAK1), which are involved in HCV-induced type I IFN production. HCV-mediated activation of miR-21 expression requires viral proteins and several signaling components. Moreover, we identified a transcription factor, activating protein-1 (AP-1), which is partly responsible for miR-21 induction in response to HCV infection through PKCε/JNK/c-Jun and PKCα/ERK/c-Fos cascades. Taken together, our results indicate that miR-21 is upregulated during HCV infection and negatively regulates IFN-α signaling through MyD88 and IRAK1 and may be a potential therapeutic target for antiviral intervention.

摘要

当病毒成分被模式识别受体(如 Toll 样受体(TLRs)和视黄酸诱导基因 I(RIG-I)样螺旋酶)识别后,细胞被激活以产生 I 型干扰素(IFN)和促炎细胞因子。这些途径受到宿主的严格调控,以防止细胞的不适当反应,但病毒可以调节这些途径以增殖和传播。在这项研究中,我们揭示了一种新的机制,即丙型肝炎病毒(HCV)通过激活 microRNA-21(miR-21)来逃避免疫监视系统以增殖。我们证明了 HCV 感染上调了 miR-21,而 miR-21 反过来又抑制了 HCV 触发的 I 型 IFN 产生,从而促进了 HCV 的复制。此外,我们证明了 miR-21 靶向 TLR 信号通路中的两个重要因子,髓样分化因子 88(MyD88)和白细胞介素-1 受体相关激酶 1(IRAK1),它们参与了 HCV 诱导的 I 型 IFN 产生。HCV 介导的 miR-21 表达的激活需要病毒蛋白和几个信号成分。此外,我们鉴定了一个转录因子,激活蛋白-1(AP-1),它部分负责 HCV 感染后通过 PKCε/JNK/c-Jun 和 PKCα/ERK/c-Fos 级联反应诱导 miR-21 的表达。总之,我们的结果表明,miR-21 在 HCV 感染期间上调,并通过 MyD88 和 IRAK1 负调控 IFN-α信号通路,可能是抗病毒干预的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/1f3c807f14ca/ppat.1003248.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/430319dfb614/ppat.1003248.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/fe27f27bc27b/ppat.1003248.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/a63990d0ab8a/ppat.1003248.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/30190f725054/ppat.1003248.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/7ec7125113c9/ppat.1003248.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/41718710623c/ppat.1003248.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/df29224563cd/ppat.1003248.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/e712c39da1da/ppat.1003248.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/50641b8bb2e5/ppat.1003248.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/b40de0d41d21/ppat.1003248.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/c9354cb25c14/ppat.1003248.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/1f3c807f14ca/ppat.1003248.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/430319dfb614/ppat.1003248.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/fe27f27bc27b/ppat.1003248.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/a63990d0ab8a/ppat.1003248.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/30190f725054/ppat.1003248.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/7ec7125113c9/ppat.1003248.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/41718710623c/ppat.1003248.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/df29224563cd/ppat.1003248.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/e712c39da1da/ppat.1003248.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/50641b8bb2e5/ppat.1003248.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/b40de0d41d21/ppat.1003248.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/c9354cb25c14/ppat.1003248.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4138/3635988/1f3c807f14ca/ppat.1003248.g012.jpg

相似文献

1
HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1.HCV 诱导的 miR-21 通过靶向 MyD88 和 IRAK1 促进宿主免疫系统逃避。
PLoS Pathog. 2013;9(4):e1003248. doi: 10.1371/journal.ppat.1003248. Epub 2013 Apr 25.
2
MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.在人软骨细胞中敲低MyD88、IRAK1和TRAF6可通过损害丝裂原活化蛋白激酶(MAP激酶)的激活来抑制白细胞介素-1诱导的基质金属蛋白酶-13基因表达及启动子活性。
Cell Signal. 2007 Dec;19(12):2549-57. doi: 10.1016/j.cellsig.2007.08.013. Epub 2007 Aug 25.
3
Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1.肠道病毒71型诱导产生的has-miR-21通过靶向髓样分化因子88(MyD88)和白细胞介素-1受体相关激酶1(IRAK1)促进宿主免疫系统逃避。
Virus Res. 2017 Jun 2;237:27-36. doi: 10.1016/j.virusres.2017.05.008. Epub 2017 May 12.
4
MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.微小RNA-146a通过靶向肿瘤坏死因子受体相关因子6(TRAF6)、白细胞介素-1受体相关激酶1(IRAK1)和白细胞介素-1受体相关激酶2(IRAK2),反馈抑制巨噬细胞中视黄酸诱导基因I(RIG-I)依赖性I型干扰素的产生。
J Immunol. 2009 Aug 1;183(3):2150-8. doi: 10.4049/jimmunol.0900707. Epub 2009 Jul 13.
5
Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.丙型肝炎病毒感染受 NS3-NS4A 靶向的非经典抗病毒信号通路抑制。
J Virol. 2019 Nov 13;93(23). doi: 10.1128/JVI.00725-19. Print 2019 Dec 1.
6
Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.卡波西肉瘤相关疱疹病毒 microRNAs 靶向 IRAK1 和 MYD88,这两种蛋白都是 Toll 样受体/白介素-1R 信号转导通路的组成部分,以降低炎症细胞因子的表达。
J Virol. 2012 Nov;86(21):11663-74. doi: 10.1128/JVI.01147-12. Epub 2012 Aug 15.
7
Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.丙型肝炎病毒介导的微小RNA miR-373增强会损害JAK/STAT信号通路。
J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.
8
CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.CD40 通过激活 c-Jun N 末端激酶抑制丙型肝炎病毒在原代人肝细胞中的复制,而不依赖于干扰素通路。
Hepatology. 2013 Jan;57(1):23-36. doi: 10.1002/hep.25966.
9
MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.微小RNA-146a-5p通过抑制Toll样受体4信号通路负向调节脂多糖刺激的人肝星状细胞中促炎细胞因子的分泌和细胞活化。
Int J Mol Sci. 2016 Jul 7;17(7):1076. doi: 10.3390/ijms17071076.
10
Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.丙型肝炎病毒表达期间对RIG-I依赖的干扰素信号通路的抑制以及IKKε对信号通路的恢复
J Virol. 2005 Apr;79(7):3969-78. doi: 10.1128/JVI.79.7.3969-3978.2005.

引用本文的文献

1
Dysregulated miRNA Expression and Its Association with Immune Checkpoints in Head and Neck Cancer.头颈部癌中miRNA表达失调及其与免疫检查点的关联
Cancers (Basel). 2025 Jun 27;17(13):2169. doi: 10.3390/cancers17132169.
2
Expression of microRNAs in the detection and therapeutic roles of viral infections: Mechanisms and applications.微小RNA在病毒感染检测及治疗作用中的表达:机制与应用
J Virus Erad. 2025 Mar 12;11(1):100586. doi: 10.1016/j.jve.2025.100586. eCollection 2025 Mar.
3
Discovering the role of microRNAs and exosomal microRNAs in chest and pulmonary diseases: a spotlight on chronic obstructive pulmonary disease.

本文引用的文献

1
Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon.主要穹窿蛋白:一种通过诱导 I 型干扰素来抵抗病毒复制的病毒诱导宿主因子。
Hepatology. 2012 Jul;56(1):57-66. doi: 10.1002/hep.25642. Epub 2012 Jun 1.
2
A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication.一种肝脏特异性 microRNA 与乙型肝炎病毒的高度保守 RNA 序列结合,并负调控病毒基因的表达和复制。
FASEB J. 2011 Dec;25(12):4511-21. doi: 10.1096/fj.11-187781. Epub 2011 Sep 8.
3
The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses.
探讨 microRNAs 和外泌体 microRNAs 在胸肺疾病中的作用:聚焦慢性阻塞性肺疾病。
Mol Genet Genomics. 2024 Nov 11;299(1):107. doi: 10.1007/s00438-024-02199-2.
4
The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.表观遗传机制在丙型肝炎感染发病机制中的作用。
Biomolecules. 2024 Aug 10;14(8):986. doi: 10.3390/biom14080986.
5
A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection.关于微小RNA与病毒发病机制及感染之间相互作用的全面综述。
Med Res Rev. 2025 Mar;45(2):349-425. doi: 10.1002/med.22073. Epub 2024 Aug 26.
6
miR-21 Expressed by Dermal Fibroblasts Enhances Skin Wound Healing Through the Regulation of Inflammatory Cytokine Expression.由真皮成纤维细胞表达的miR-21通过调节炎性细胞因子表达促进皮肤伤口愈合。
Inflammation. 2024 Apr;47(2):572-590. doi: 10.1007/s10753-023-01930-2. Epub 2023 Dec 2.
7
Biomarkers for Assessment of Human Immunodeficiency Virus and its Co-Infection with Hepatitis B and Hepatitis C Viruses: A Comprehensive Review.用于评估人类免疫缺陷病毒及其与乙型肝炎和丙型肝炎病毒合并感染的生物标志物:综述
Iran J Pathol. 2023 Summer;18(3):230-243. doi: 10.30699/IJP.2023.1972384.3009. Epub 2023 Jul 15.
8
MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets.微生物在传染病中的作用:潜在的诊断生物标志物和治疗靶点。
Clin Microbiol Rev. 2023 Dec 20;36(4):e0001523. doi: 10.1128/cmr.00015-23. Epub 2023 Nov 1.
9
Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma.Ras丝裂原活化蛋白激酶信号传导与Ras激酶抑制因子作为肝细胞癌的治疗靶点
J Liver Cancer. 2021 Mar;21(1):1-11. doi: 10.17998/jlc.21.1.1. Epub 2021 Mar 31.
10
miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome.微小RNA作为新冠病毒感染及并发症的病程、严重程度和预后的潜在生物标志物
Diagnostics (Basel). 2023 Mar 14;13(6):1091. doi: 10.3390/diagnostics13061091.
肠道病毒 71 型的 3C 蛋白抑制视黄酸诱导基因 I 介导体干扰素调节因子 3 的激活和 I 型干扰素应答。
J Virol. 2010 Aug;84(16):8051-61. doi: 10.1128/JVI.02491-09. Epub 2010 Jun 2.
4
MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection.微小 RNA-98 和 let-7 调控细胞因子信号转导抑制因子 4 在隐孢子虫感染胆管上皮细胞中的表达。
J Infect Dis. 2010 Jul 1;202(1):125-35. doi: 10.1086/653212.
5
MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1.微小 RNA-21 和微小 RNA-148a 通过直接和间接靶向 DNA 甲基转移酶 1 导致狼疮 CD4+T 细胞中的 DNA 低甲基化。
J Immunol. 2010 Jun 15;184(12):6773-81. doi: 10.4049/jimmunol.0904060. Epub 2010 May 17.
6
MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand.微小 RNA-21 是 AKT 的下游效应因子,通过抑制 Fas 配体来介导其抗细胞凋亡作用。
J Biol Chem. 2010 Jun 25;285(26):20281-90. doi: 10.1074/jbc.M110.109207. Epub 2010 Apr 19.
7
Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells.系统鉴定丙型肝炎病毒感染的人肝癌细胞中的 microRNA 和信使 RNA 谱。
Virology. 2010 Mar 1;398(1):57-67. doi: 10.1016/j.virol.2009.11.036. Epub 2009 Dec 14.
8
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.通过 microRNA miR-21 靶向促炎肿瘤抑制因子 PDCD4 对 TLR4 进行负调控。
Nat Immunol. 2010 Feb;11(2):141-7. doi: 10.1038/ni.1828. Epub 2009 Nov 29.
9
Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.人类肝脏中丙型肝炎病毒相关的微小RNA-信使核糖核酸调控模块的计算识别
BMC Genomics. 2009 Aug 11;10:373. doi: 10.1186/1471-2164-10-373.
10
MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.微小RNA-146a通过靶向肿瘤坏死因子受体相关因子6(TRAF6)、白细胞介素-1受体相关激酶1(IRAK1)和白细胞介素-1受体相关激酶2(IRAK2),反馈抑制巨噬细胞中视黄酸诱导基因I(RIG-I)依赖性I型干扰素的产生。
J Immunol. 2009 Aug 1;183(3):2150-8. doi: 10.4049/jimmunol.0900707. Epub 2009 Jul 13.